News
NICE recommends Merck’s Tepmetko for lung cancer treatment
The National Institute for Health and Care Excellence (NICE) has recommended Tepmetko (tepotinib) for the treatment of adult patients in the UK with advanced non-small cell lung cancer (NSCLC).